ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1745

High Emotional Distress Predicts Suboptimal Cardiovascular Health Among Patients with Juvenile-Onset Lupus and Dermatomyositis: Longitudinal Analysis of the Lupus Erythematosus and Dermatomyositis Stress and Cardiovascular Health Cohort Study

Kaveh Ardalan1, Angel Davalos1, Hwanhee Hong1, Bryce Reeve1, Christoph Hornik1, M. Anthony Moody1, Donald Lloyd-Jones2, Eveline Wu3, Audrey Ward4, Simisola Gbadegesin5, Rebecca Sadun6, Jeffrey Dvergsten7, Lauren Covert1, Ann Reed1, Mark Connelly8 and Laura Schanberg9, 1Duke University School of Medicine, Durham, NC, 2Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 3UNC Chapel Hill, Chapel Hill, NC, 4Children's National Hospital, Washington, DC, 5Wake Forest University School of Medicine, Winston-Salem, NC, 6Duke University, Durham, NC, 7Duke University Hospital, Hillsborough, NC, 8Children’s Mercy Kansas City/University of Missouri-Kansas City School of Medicine, Kansas City, MO, 9Duke University Medical Center, DURHAM, NC

Meeting: ACR Convergence 2025

Keywords: Cardiovascular, dermatomyositis, mental health, Pediatric rheumatology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: Abstracts: Pediatric Rheumatology – Clinical II (1740–1745)

Session Type: Abstract Session

Session Time: 11:15AM-11:30AM

Background/Purpose: Juvenile lupus & dermatomyositis (JSLE/JDM) patients experience high emotional distress and premature loss of cardiovascular health (CVH), defined as protective factors against cardiovascular disease (CVD). Although general pediatric studies show emotional distress is associated with worse CVH, the contribution of emotional distress to suboptimal CVH in JSLE/JDM has not been studied. We present longitudinal analyses from the Lupus Erythematosus & Dermatomyositis Stress & Cardiovascular Health (LEADS-CV) cohort, the first multicenter biopsychosocial study assessing emotional distress and CVH in JSLE/JDM.

Methods: Of 83 LEADS-CV participants (5-22yo), 72 with non-missing data on study measures at ≥1 study visit (baseline, 6 & 12 months) were included for analysis. Emotional distress measures included PROMIS® Pediatric Psychological Stress Experiences, Depressive Symptoms, and Anxiety (self-report in ≥8yo, parent-report in 5-7yo). CVH Behaviors (diet quality screener, self-report ≥12yo, parent-report < 12yo; PROMIS Pediatric Physical Activity self-report ≥8yo, parent-report 5-7yo) and CVH Factors (body mass index, blood pressure, non-HDL cholesterol, HbA1c) were assessed. CVH Summary (CVH-S, all 6 indicators), Behaviors (CVH-B), and Factors (CVH-F) scores were determined using AHA guidelines (0 = very poor, 100 = ideal). Linear mixed-effects models (LMMs) assessed associations of emotional distress and CVH-S/-B/-F, adjusted for gender, race/ethnicity, diagnosis, disease activity, steroid use, and time. Growth mixture models (GMMs) identified latent trajectories of emotional distress and CVH-S/-B/-F. Proportions of patients in CVH-S/-B/-F latent trajectories were compared across emotional distress latent trajectories.

Results: LMM results (Table 2) show JSLE and active disease are associated with lower CVH-S and CVH-F scores across all models. Higher PROMIS Anxiety is associated with lower CVH-S and CVH-F. Increasing age is associated with lower CVH-B . Across models, slightly higher CVH-S was estimated at the 12-month visit compared with baseline. Among patients with maximal (79.8) vs minimal (38.8) PROMIS Anxiety scores, estimated CVH-S and CVH-F scores were lower (-7.79 and -10.25, respectively). GMMs identified latent trajectories of CVH and emotional distress with clinically distinct score distributions; worse CVH-S/-B/-F was more common in higher emotional distress latent trajectory classes, with 69-78% of patients in higher emotional distress latent trajectory classes having poor CVH-B (Table 3).

Conclusion: Higher emotional distress is associated with worse CVH in JSLE/JDM. Severe anxiety is associated with sufficiently large decreases in CVH-S/-F that higher mid-life risk of CVD events would be expected. Low CVH-B is present in most JSLE/JDM patients following high emotional distress latent trajectories. Interventions are needed to address dual risks of emotional distress and suboptimal CVH in JSLE/JDM. Our ongoing work will identify mediators by which emotional distress worsens CVH and child/parent targets for stress reduction and CVH promotion interventions in JSLE/JDM.

Supporting image 1Table 1: Comparison of Baseline Visit Participant Characteristics for LEADS-CV Full Cohort Versus Analytic Sample

Supporting image 2Table 2: Linear Mixed-Effects Models (LMM) (n = 72 with 171 observations)

Supporting image 3Table 3: Latent Trajectory Classes of Emotional Distress and Cardiovascular Health in LEADS-CV Participants


Disclosures: K. Ardalan: Cabaletta Bio, 1, 2, SingHealth, 12, honorarium paid directly to institution (not investigator) for grant pre-review program participation; A. Davalos: None; H. Hong: None; B. Reeve: None; C. Hornik: Cytokinetics, 1, Emmes Corporation, 12, DSMB, Tellus, 2; M. Moody: Grid Therapeutics, LLC., 12,; D. Lloyd-Jones: None; E. Wu: Pharming Healthcare, Inc, 2, 6, Sumitomo Pharma, 2; A. Ward: None; S. Gbadegesin: None; R. Sadun: The Expert Institute, 12,; J. Dvergsten: None; L. Covert: None; A. Reed: None; M. Connelly: None; L. Schanberg: Bristol-Myers Squibb(BMS), 5, Sanofi, 12, DSMB, UCB, 12, DSMB.

To cite this abstract in AMA style:

Ardalan K, Davalos A, Hong H, Reeve B, Hornik C, Moody M, Lloyd-Jones D, Wu E, Ward A, Gbadegesin S, Sadun R, Dvergsten J, Covert L, Reed A, Connelly M, Schanberg L. High Emotional Distress Predicts Suboptimal Cardiovascular Health Among Patients with Juvenile-Onset Lupus and Dermatomyositis: Longitudinal Analysis of the Lupus Erythematosus and Dermatomyositis Stress and Cardiovascular Health Cohort Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/high-emotional-distress-predicts-suboptimal-cardiovascular-health-among-patients-with-juvenile-onset-lupus-and-dermatomyositis-longitudinal-analysis-of-the-lupus-erythematosus-and-dermatomyositis-str/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-emotional-distress-predicts-suboptimal-cardiovascular-health-among-patients-with-juvenile-onset-lupus-and-dermatomyositis-longitudinal-analysis-of-the-lupus-erythematosus-and-dermatomyositis-str/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology